4//SEC Filing
CORIXA CORP 4
Accession 0001209191-05-037208
CIK 0001042561operating
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 7:19 PM ET
Size
59.1 KB
Accession
0001209191-05-037208
Insider Transaction Report
Form 4
CORIXA CORPCRXA
BURRIS MICHELLE
Sr. Vice President, CFO
Transactions
- Exercise/Conversion
Common Stock
2005-07-12$3.95/sh+149,998$592,492→ 211,867 total - Disposition to Issuer
Common Stock
2005-07-12$4.40/sh−149,998$659,991→ 61,869 total - Disposition to Issuer
Incentive Stock Option
2005-07-12−9,530→ 0 totalExercise: $13.45From: 2005-07-12Exp: 2011-10-26→ Common Stock (9,530 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−4,877→ 0 totalExercise: $17.00From: 2005-07-12Exp: 2009-12-31→ Common Stock (4,877 underlying) - Exercise/Conversion
Common Stock
2005-07-12$3.95/sh+2$8→ 61,869 total - Disposition to Issuer
Incentive Stock Option
2005-07-12−26,170→ 0 totalExercise: $8.69From: 2005-07-12Exp: 2009-01-29→ Common Stock (26,170 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−5,673→ 0 totalExercise: $15.07From: 2005-07-12Exp: 2011-12-31→ Common Stock (5,673 underlying) - Exercise/Conversion
Incentive Stock Option
2005-07-12−17,171→ 0 totalExercise: $0.99From: 2005-07-12Exp: 2007-02-27→ Common Stock (17,171 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−66,914→ 0 totalExercise: $5.70From: 2005-07-12Exp: 2012-06-14→ Common Stock (66,914 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−12,330→ 0 totalExercise: $8.69From: 2005-07-12Exp: 2009-01-29→ Common Stock (12,330 underlying) - Exercise/Conversion
Incentive Stock Option
2005-07-12−2→ 0 totalExercise: $3.95From: 2005-07-12Exp: 2014-12-15→ Common Stock (2 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−19,183→ 0 totalExercise: $6.04From: 2005-07-12Exp: 2013-12-31→ Common Stock (19,183 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−8,086→ 0 totalExercise: $5.70From: 2005-07-12Exp: 2012-06-14→ Common Stock (8,086 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−4,827→ 0 totalExercise: $15.70From: 2005-07-12Exp: 2011-12-13→ Common Stock (4,827 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−21,317→ 0 totalExercise: $6.04From: 2005-07-12Exp: 2013-12-31→ Common Stock (21,317 underlying) - Exercise/Conversion
Common Stock
2005-07-12$0.99/sh+17,171$16,999→ 31,564 total - Exercise/Conversion
Common Stock
2005-07-12$0.99/sh+30,303$30,000→ 61,867 total - Disposition to Issuer
Incentive Stock Option
2005-07-12−4,062→ 0 totalExercise: $6.41From: 2005-07-12Exp: 2013-01-03→ Common Stock (4,062 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−46,710→ 0 totalExercise: $13.45From: 2005-07-12Exp: 2011-10-26→ Common Stock (46,710 underlying) - Exercise/Conversion
Incentive Stock Option
2005-07-12−30,303→ 0 totalExercise: $0.99From: 2005-07-12Exp: 2007-02-27→ Common Stock (30,303 underlying) - Disposition to Issuer
Common Stock
2005-07-12$4.40/sh−61,869$272,224→ 0 total - Exercise/Conversion
Non-Qualified Stock Option
2005-07-12−149,998→ 0 totalExercise: $3.95From: 2005-07-12Exp: 2014-12-15→ Common Stock (149,998 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−9,297→ 0 totalExercise: $9.50From: 2005-07-12Exp: 2008-01-16→ Common Stock (9,297 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−58,760→ 0 totalExercise: $13.45From: 2005-07-12Exp: 2011-10-26→ Common Stock (58,760 underlying) - Disposition to Issuer
Incentive Stock Option
2005-07-12−3,453→ 0 totalExercise: $9.50From: 2005-07-12Exp: 2008-01-16→ Common Stock (3,453 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−10,938→ 0 totalExercise: $6.41From: 2005-07-12Exp: 2013-01-03→ Common Stock (10,938 underlying) - Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−8,123→ 0 totalExercise: $17.00From: 2005-07-12Exp: 2009-12-31→ Common Stock (8,123 underlying)
Footnotes (2)
- [F1]Pursuant to the Merger Agreement with GSK, these options were canceled at the time of the Merger. Net cash consideration was received.
- [F2]Pursuant to the Merger Agreement with GSK, the underlying option was canceled at the time of the Merger. No net cash consideration was received.
Documents
Issuer
CORIXA CORP
CIK 0001042561
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042561
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 7:19 PM ET
- Size
- 59.1 KB